Published in J Clin Microbiol on June 01, 2003
Rotavirus and severe childhood diarrhea. Emerg Infect Dis (2006) 7.80
Acute childhood diarrhoea in northern Ghana: epidemiological, clinical and microbiological characteristics. BMC Infect Dis (2007) 1.20
Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial. BMC Infect Dis (2012) 1.12
Prevalence of enteropathogenic viruses and molecular characterization of group A rotavirus among children with diarrhea in Dar es Salaam Tanzania. BMC Public Health (2007) 1.06
Rotavirus genotypes associated with childhood severe acute diarrhoea in southern Ghana: a cross-sectional study. Virol J (2013) 0.88
Methods and challenges in measuring the impact of national pneumococcal and rotavirus vaccine introduction on morbidity and mortality in Malawi. Vaccine (2015) 0.88
Identification of novel Ghanaian G8P[6] human-bovine reassortant rotavirus strain by next generation sequencing. PLoS One (2014) 0.87
Surveillance study (2000 to 2001) of G- and P-type human rotaviruses circulating in South Korea. J Clin Microbiol (2004) 0.86
Molecular epidemiology of rotavirus in Central and Southeastern Europe. J Clin Microbiol (2007) 0.85
Emergence of unusual G6P[6] rotaviruses in children, Burkina Faso, 2009-2010. Emerg Infect Dis (2012) 0.83
Serotype G9 rotavirus infections in adults in Sweden. J Clin Microbiol (2005) 0.83
Molecular epidemiology of G9 rotaviruses in Taiwan between 2000 and 2002. J Clin Microbiol (2006) 0.82
Prevalence of rotavirus genotypes in children younger than 5 years of age before the introduction of a universal rotavirus vaccination program: report of rotavirus surveillance in Turkey. PLoS One (2014) 0.81
Prevalence and Genetic Diversity of Enteric Viruses in Children with Diarrhea in Ouagadougou, Burkina Faso. PLoS One (2016) 0.81
The global spread of rotavirus G10 strains: Detection in Ghanaian children hospitalized with diarrhea. J Infect Dis (2010) 0.80
Sequence analysis of human rotavirus strains: comparison of clinical isolates from Northern and Southern Italy. Eur J Clin Microbiol Infect Dis (2011) 0.75
Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol (1990) 10.23
Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol (1992) 8.25
Serological analysis of the subgroup protein of rotavirus, using monoclonal antibodies. Infect Immun (1983) 5.85
Rapid diagnosis of rotavirus infection by direct detection of viral nucleic acid in silver-stained polyacrylamide gels. J Clin Microbiol (1982) 5.80
Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus. J Virol (1983) 5.44
Interventions for the control of diarrhoeal diseases among young children: rotavirus and cholera immunization. Bull World Health Organ (1985) 3.59
Rotavirus G and P types in children with acute diarrhea in Blantyre, Malawi, from 1997 to 1998: predominance of novel P[6]G8 strains. J Med Virol (1999) 2.33
Evidence of high-frequency genomic reassortment of group A rotavirus strains in Bangladesh: emergence of type G9 in 1995. J Clin Microbiol (1999) 2.31
Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Wkly Rep (1999) 2.24
Characterisation of rotaviruses from children treated at a London hospital during 1996: emergence of strains G9P2A[6] and G3P2A[6]. J Med Virol (2000) 1.59
Molecular characterization of serotype G9 rotavirus strains from a global collection. Virology (2000) 1.43
Interspecies transmission of rotaviruses studied from the perspective of genogroup. Microbiol Immunol (1993) 1.33
Characterisation of rotavirus G9 strains isolated in the UK between 1995 and 1998. J Med Virol (2000) 1.23
Prevalence of unusual human rotavirus strains in Ghanaian children. J Med Virol (2001) 1.21
Emerging group-A rotavirus and a nosocomial outbreak of diarrhoea. Lancet (2000) 1.20
Natural history of human rotavirus infection. Arch Virol Suppl (1996) 1.17
Rotavirus G and P genotypes in rural Ghana. J Clin Microbiol (2001) 1.09
Apparent re-emergence of serotype G9 in 1995 among rotaviruses recovered from Japanese children hospitalized with acute gastroenteritis. Microbiol Immunol (2000) 1.05
Seasonality of rotavirus infection in Ghana. Ann Trop Paediatr (1994) 1.04
Rotavirus serotype G5: an emerging cause of epidemic childhood diarrhea. Vaccine (1999) 1.02
Circulation of the novel G9 and G8 rotavirus strains in Nigeria in 1998/1999. J Med Virol (2002) 0.96
Rotavirus subgroups, G serotypes, and electrophoretypes in cases of nosocomial infantile diarrhoea in Belém, Brazil. J Trop Pediatr (1999) 0.87
Rotavirus vaccinology: good news and bad news. J Pediatr Gastroenterol Nutr (2000) 0.82
RAS is regulated by the let-7 microRNA family. Cell (2005) 30.24
The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res (2007) 9.32
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med (2011) 6.85
Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J (2010) 5.43
Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant. Lancet (2004) 5.25
The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle (2008) 4.95
Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours. AIDS (2007) 4.40
Surgical treatment of permanent diaphragm paralysis after interscalene nerve block for shoulder surgery. Anesthesiology (2013) 4.25
Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol (2011) 3.87
Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis (2008) 3.84
Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res (2010) 3.21
An optimized isolation and labeling platform for accurate microRNA expression profiling. RNA (2005) 3.12
Isoniazid's bactericidal activity ceases because of the emergence of resistance, not depletion of Mycobacterium tuberculosis in the log phase of growth. J Infect Dis (2006) 3.04
Herpes simplex virus type 2 infection increases HIV incidence: a prospective study in rural Tanzania. AIDS (2002) 2.93
Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Mol Ther (2009) 2.92
Accelerating reproductive and child health programme impact with community-based services: the Navrongo experiment in Ghana. Bull World Health Organ (2006) 2.82
Viral gastroenteritis outbreaks in Europe, 1995-2000. Emerg Infect Dis (2003) 2.79
Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice. Mol Ther (2011) 2.75
Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: the state of the evidence. Lancet Infect Dis (2003) 2.75
The promise of microRNA replacement therapy. Cancer Res (2010) 2.68
Sufficiently important difference: expanding the framework of clinical significance. Med Decis Making (2005) 2.65
Hunting for consensus: reconciling bushmeat harvest, conservation, and development policy in West and Central Africa. Conserv Biol (2007) 2.50
Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis (2010) 2.50
Pneumococcal vaccination in developing countries. Lancet (2006) 2.45
Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana. J Infect Dis (2002) 2.40
Validity of the alcohol use disorders identification test in college students. Alcohol Clin Exp Res (2004) 2.30
Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J Virol (2004) 2.28
Malaria transmission dynamics at a site in northern Ghana proposed for testing malaria vaccines. Trop Med Int Health (2004) 2.28
Molecular epidemiology of human enterovirus 71 in the United Kingdom from 1998 to 2006. J Clin Microbiol (2008) 2.24
International collaborative study to compare reverse transcriptase PCR assays for detection and genotyping of noroviruses. J Clin Microbiol (2003) 2.23
Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratories. J Infect Dis (2007) 2.22
A randomized, controlled trial of an aerosolized vaccine against measles. N Engl J Med (2015) 2.16
Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men. Gastroenterology (2009) 2.10
Diagnosing norovirus-associated infectious intestinal disease using viral load. BMC Infect Dis (2009) 2.09
Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity. Inhal Toxicol (2007) 2.06
Does vitamin A supplementation interact with routine vaccinations? An analysis of the Ghana Vitamin A Supplementation Trial. Am J Clin Nutr (2009) 2.04
Global distribution of measles genotypes and measles molecular epidemiology. J Infect Dis (2011) 2.03
Isoniazid bactericidal activity and resistance emergence: integrating pharmacodynamics and pharmacogenomics to predict efficacy in different ethnic populations. Antimicrob Agents Chemother (2007) 2.02
The pulmonary toxicology of ultrafine particles. J Aerosol Med (2002) 2.02
Demographic Surveillance Sites and emerging challenges in international health. Bull World Health Organ (2006) 1.93
Seasonal malaria attack rates in infants and young children in northern Ghana. Am J Trop Med Hyg (2002) 1.91
Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology (2009) 1.88
Mumps outbreaks across England and Wales in 2004: observational study. BMJ (2005) 1.87
Community incidence of norovirus-associated infectious intestinal disease in England: improved estimates using viral load for norovirus diagnosis. Am J Epidemiol (2010) 1.86
Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway. Cancer Res (2007) 1.83
United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction. Pediatr Infect Dis J (2011) 1.83
Personalized exposure assessment: promising approaches for human environmental health research. Environ Health Perspect (2005) 1.83
Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis (2007) 1.79
Early identification of common-source foodborne virus outbreaks in Europe. Emerg Infect Dis (2003) 1.75
The impact of the Navrongo Project on contraceptive knowledge and use, reproductive preferences, and fertility. Stud Fam Plann (2002) 1.73
Dendrodendritic inhibition and simulated odor responses in a detailed olfactory bulb network model. J Neurophysiol (2003) 1.72
Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants. Cancer Epidemiol Biomarkers Prev (2009) 1.70
Patterns of age-specific mortality in children in endemic areas of sub-Saharan Africa. Am J Trop Med Hyg (2007) 1.70
A two-compartment mathematical model of endotoxin-induced inflammatory and physiologic alterations in swine. Crit Care Med (2012) 1.69
Seasonal profiles of malaria infection, anaemia, and bednet use among age groups and communities in northern Ghana. Trop Med Int Health (2003) 1.67
Severe falciparum malaria in young children of the Kassena-Nankana district of northern Ghana. Malar J (2007) 1.67
Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J Exp Med (2002) 1.66
Phenoxodiol--an isoflavone analog--induces apoptosis in chemoresistant ovarian cancer cells. Oncogene (2003) 1.65
Improving the care of patients with regard to chemotherapy-induced nausea and emesis: the effect of feedback to clinicians on adherence to antiemetic prescribing guidelines. J Clin Oncol (2003) 1.64
Diagnosing rotavirus A associated IID: Using ELISA to identify a cut-off for real time RT-PCR. J Clin Virol (2009) 1.59
Neonatal measles immunity in rural Kenya: the influence of HIV and placental malaria infections on placental transfer of antibodies and levels of antibody in maternal and cord serum samples. J Infect Dis (2005) 1.56
Apoptosis in Parkinson's disease: signals for neuronal degradation. Ann Neurol (2003) 1.55
Distinct microRNA expression profiles in prostate cancer stem/progenitor cells and tumor-suppressive functions of let-7. Cancer Res (2012) 1.55
Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis. J Allergy Clin Immunol (2011) 1.49
Gate-keeping and women's health seeking behaviour in Navrongo, northern Ghana. Afr J Reprod Health (2003) 1.48
United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann Thorac Surg (2008) 1.47
Pharmacodynamics of β-lactamase inhibition by NXL104 in combination with ceftaroline: examining organisms with multiple types of β-lactamases. Antimicrob Agents Chemother (2011) 1.46
Learning to work together: developing academic and community research partnerships. WMJ (2004) 1.45
High-throughput RNAi screening in vitro: from cell lines to primary cells. RNA (2005) 1.45
Toric Implantable Collamer Lens for moderate to high myopic astigmatism. Ophthalmology (2007) 1.45
Randomized trial of surgical cutdown versus percutaneous access in transfemoral TAVR. Catheter Cardiovasc Interv (2013) 1.45
Indigenous hepatitis E virus infection in England: more common than it seems. J Clin Virol (2009) 1.44
Serum microRNA biomarkers for detection of non-small cell lung cancer. PLoS One (2012) 1.43
Molecular epidemiology of pneumococci obtained from Gambian children aged 2-29 months with invasive pneumococcal disease during a trial of a 9-valent pneumococcal conjugate vaccine. BMC Infect Dis (2008) 1.43
Wheezing, allergy, and parasite infection in children in urban and rural Ethiopia. Am J Respir Crit Care Med (2003) 1.42
The elimination of indigenous measles transmission in England and Wales. J Infect Dis (2003) 1.42
Incidence and risk factors of paediatric rotavirus diarrhoea in northern Ghana. Trop Med Int Health (2003) 1.42
Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain. Curr Med Res Opin (2006) 1.41
Macrophage inhibitory cytokine-1: a novel biomarker for p53 pathway activation. Mol Cancer Ther (2003) 1.41
Characterization of G10P[11] rotaviruses causing acute gastroenteritis in neonates and infants in Vellore, India. J Clin Microbiol (2004) 1.41
Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg (2007) 1.40
Tracheary element differentiation. Annu Rev Plant Biol (2007) 1.39
H3ABioNet, a sustainable pan-African bioinformatics network for human heredity and health in Africa. Genome Res (2015) 1.39
Olden times: looking back on a career at the NIEHS. Environ Health Perspect (2004) 1.38
Early qualitative risk assessment of the emerging zoonotic potential of animal diseases. BMJ (2005) 1.38
Seasonality and outbreak of a predominant Streptococcus pneumoniae serotype 1 clone from The Gambia: expansion of ST217 hypervirulent clonal complex in West Africa. BMC Microbiol (2008) 1.35
Ranibizumab for choroidal neovascularization secondary to causes other than age-related macular degeneration: a phase I clinical trial. Ophthalmology (2010) 1.32
Suppression of human immunodeficiency virus replication during acute measles. J Infect Dis (2002) 1.31
Brief physician advice for heavy drinking college students: a randomized controlled trial in college health clinics. J Stud Alcohol Drugs (2010) 1.30
Targeting the mitochondria activates two independent cell death pathways in ovarian cancer stem cells. Mol Cancer Ther (2011) 1.28
A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum. Clin Infect Dis (2003) 1.28
miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia. Exp Hematol (2011) 1.27
Molecular mechanism of phenoxodiol-induced apoptosis in ovarian carcinoma cells. Cancer (2006) 1.27
Spatio-temporal malaria transmission patterns in Navrongo demographic surveillance site, northern Ghana. Malar J (2013) 1.27
Cigarette smoking and associated health risks among students at five universities. Nicotine Tob Res (2009) 1.26